Login
$CCCC
$3.21 +$0.23 (7.72%) Close

Company Executives

$CCCC Management Team

Mr. Andrew Hirsch

President

Chief Executive Officer

Director

Age 54
Compensation $5.240M USD
Sex Male

Ms. Kelly Schick

Chief People Officer

Age 45
Compensation -
Sex Female

Dr. Paige Mahaney

Chief Scientific Officer

Age 55
Compensation -
Sex Female

Mr. Leonard Reyno

Chief Medical Officer

Age 63
Compensation $2.314M USD
Sex Male

Dr. Kenneth Anderson

Independent Director

Co-Founder

Age 73
Compensation $176.6K USD
Sex Male

Ms. Kendra Adams

Chief Financial Officer

Treasurer

Age 48
Compensation $2.197M USD
Sex Female

Dr. Scott Boyle

Chief Business Officer

Age 47
Compensation $3.914M USD
Sex Male

Ms. Jolie Siegel

Chief Legal Officer

Corporate Secretary

Age 48
Compensation $3.375M USD
Sex Female

Ms. Courtney Solberg

Senior Manager - Investor Relations

Age -
Compensation -
Sex Female

Mr. Ronald Cooper

Independent Chairman of the Board

Age 62
Compensation $346.2K USD
Sex Male
Directors
9
serving now
Independent
5 of 5
stated in the proxy; 4 not stated
Average tenure
4.2 years
from year joined
CEO also chairs the board
No
Ronald Harold Wilfred Cooper
Director Age On board Independent Committees Other public boards 2025 pay Source
Andrew J. Hirsch
55 2020
6 years
Not stated None stated Editas Medicine, Inc. Paid as CEO
Utpal Koppikar
55 2022
4 years
Independent None stated None stated $100,499
Stephen Fawell, Ph.D.
66 2024
2 years
Not stated
Science and Technology Committee
None stated $85,499
Kenneth C. Anderson, M.D.
74 2015
11 years
Not stated
Science and Technology Committee
None stated $85,499
Laura Bessen, M.D.
63 2022
4 years
Not stated
Science and Technology Committee
None stated $90,249
Owen Hughes
51 2023
3 years
Independent None stated Xoma Royalty Corp $89,958
Ronald Harold Wilfred Cooper
63 2024
2 years
Independent None stated enGene Holdings, Inc. $119,249
Donna Grogan, M.D.
69 2022
4 years
Independent None stated None stated $96,999
Steven Hoerter
55 2024
2 years
Independent None stated MBX Biosciences, Inc., Oric Pharmaceuticals, Inc. Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support